| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/13/2000 | WO2000000620A3 Dna encoding methymycin and pikromycin |
| 04/13/2000 | WO2000000608A3 Immune system molecules |
| 04/13/2000 | WO2000000588A3 Porcine spinal cord cells and their use in spinal cord repair |
| 04/13/2000 | WO1999065924A3 Preparation and use of superior vaccines |
| 04/13/2000 | WO1999064565A9 Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells |
| 04/13/2000 | WO1999051265A9 Nucleic acid encoding hyaluronan synthase and methods of use |
| 04/13/2000 | CA2347120A1 Nlk1 -interacting proteins |
| 04/13/2000 | CA2346497A1 Spodoptera frugiperda single cell suspension cell line in serum-free media, methods of producing and using |
| 04/13/2000 | CA2346496A1 Novel th2-specific molecules and uses thereof |
| 04/13/2000 | CA2346452A1 Methods and adjuvants for stimulating mucosal immunity |
| 04/13/2000 | CA2346339A1 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage |
| 04/13/2000 | CA2346217A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 04/13/2000 | CA2346134A1 G protein-coupled receptor resembling the thrombin receptor |
| 04/13/2000 | CA2346068A1 A novel lymphocyte population expressing intracellular mo2 |
| 04/13/2000 | CA2345881A1 Bone marrow-derived serum proteins |
| 04/13/2000 | CA2345477A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation |
| 04/13/2000 | CA2345377A1 Novel secreted proteins and polynucleotides encoding them |
| 04/13/2000 | CA2345215A1 Fusions of scaffold proteins with random peptide libraries |
| 04/13/2000 | CA2345203A1 Dna shuffling to produce nucleic acids for mycotoxin detoxification |
| 04/13/2000 | CA2345045A1 G-protein coupled receptor proteins |
| 04/13/2000 | CA2345023A1 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| 04/13/2000 | CA2344995A1 Cancer associated antigens and uses therefor |
| 04/13/2000 | CA2344973A1 Oxidoreductase molecules |
| 04/13/2000 | CA2344593A1 Hypersensitive response elicitor fragments which are active but do not elicit a hypersensitive response |
| 04/13/2000 | CA2344269A1 Therapeutically active proteins in plants |
| 04/13/2000 | CA2344266A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 04/13/2000 | CA2341351A1 Alpha-2/delta gene |
| 04/13/2000 | CA2335391A1 Akt compositions for enhancing survival of cells |
| 04/13/2000 | CA2313169A1 Engraftable neural progenitor and stem cells for brain tumor therapy |
| 04/12/2000 | EP0992585A2 Human calcium channel compositions and methods |
| 04/12/2000 | EP0992584A2 Purified mammalian FLT3 ligands and agonists and antagonists thereof |
| 04/12/2000 | EP0992579A1 Stem cell factor |
| 04/12/2000 | EP0992578A1 Methods for labeling intracytoplasmic molecules |
| 04/12/2000 | EP0991774A1 Method for increasing secretion of proteins in eukaryotic host cells |
| 04/12/2000 | EP0991771A2 Lentivirus based vector and vector system |
| 04/12/2000 | EP0991770A2 Prostate cancer gene |
| 04/12/2000 | EP0991769A2 A method for plant protection against insects or nematodes |
| 04/12/2000 | EP0991766A1 Regulation of quinolate phosphoribosyl transferase expression |
| 04/12/2000 | EP0991764A1 Regulatory sequences for transgenic plants |
| 04/12/2000 | EP0991760A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof |
| 04/12/2000 | EP0991759A1 Ntn-2 member of tnf ligand family |
| 04/12/2000 | EP0991758A1 Smad6 and uses thereof |
| 04/12/2000 | EP0991757A1 Novel tumor antigens |
| 04/12/2000 | EP0991661A2 Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
| 04/12/2000 | EP0991426A1 Improved method for transferring nucleic acid into the striped muscle and combination therefor |
| 04/12/2000 | EP0991417A1 Complex formation between dsdna and oligomer of heterocycles |
| 04/12/2000 | EP0991402A1 Poly(vinyl alcohol) cryogel |
| 04/12/2000 | EP0991321A1 Tolerance to natural antibody antigens |
| 04/12/2000 | EP0814838A4 Antigen presenting system and methods for activation of t-cells |
| 04/12/2000 | CN1250479A Modulators of the function of receptors of the TNF/NGF receptor family |
| 04/12/2000 | CN1250380A Bovine respiratory and enteric coronavirus as a vaccine |
| 04/12/2000 | CN1250055A Production of recombination human lactoferritin |
| 04/11/2000 | US6048965 Polypeptide that controls the premature degradation of transcripts |
| 04/11/2000 | US6048964 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
| 04/11/2000 | US6048963 Polynucleotides and polypeptides associated with benign prostatic hypertrophy |
| 04/11/2000 | US6048730 Selectable marker for development of vectors and transformation systems in plants |
| 04/11/2000 | US6048728 Cell culture medium for enhanced cell growth, culture longevity, and product expression |
| 04/11/2000 | US6048727 Cell propagation method that removes metabolic wastes during cell propagation; establishing mass transfer system, pumping nutrient fluid through container, periodically switching the flow of fluid through the container |
| 04/11/2000 | US6048724 Producing mammalian transfected cell strain which expresses exogenous dna encoding erythropoietin and glucagons; for prevention or treatment of a condition in which insulin production or glucagon function is defective |
| 04/11/2000 | US6048716 Microorganism polypeptide; for infection prevention bactericides; wound healing agents |
| 04/11/2000 | US6048709 Polynucleotide sequence coding a endothelial marker polypeptide; for the detection and therapy of heart and vascular disorders |
| 04/11/2000 | US6048534 Methods and compositions for the selective regulation of chorionic prostanoids |
| 04/11/2000 | US6048527 Non-autoreactive; n-propionylated neisseria serogroup b capsular polysaccharide-protein conjugates |
| 04/11/2000 | US6048525 Implanting hematopoietic cells comprising t-lymphocyte with dna sequence that expresses thymidine kinase gene; administering ganciclovir or acyclovir; treating graft versus host disease |
| 04/11/2000 | US6048524 In vivo production and delivery of erythropoietin for gene therapy |
| 04/11/2000 | CA1340953C Non-tumorigenic cell lines for expression of genes |
| 04/07/2000 | CA2285149A1 Device for tissue engineering a bone equivalent |
| 04/06/2000 | WO2000018954A2 Use of pex in the treatment of metabolic bone diseases |
| 04/06/2000 | WO2000018952A1 Use of s-ydcb and b-ydcb, essential bacterial genes |
| 04/06/2000 | WO2000018940A1 Plants and plants cells encoding the wild type cop1 gene and the coil domain thereof |
| 04/06/2000 | WO2000018932A2 Receptor based antagonists and methods of making and using |
| 04/06/2000 | WO2000018930A1 Plant promoter |
| 04/06/2000 | WO2000018923A2 Slgp protein and nucleic acid molecule and uses therefor |
| 04/06/2000 | WO2000018919A1 Human kinesin-like motor protein |
| 04/06/2000 | WO2000018916A2 Human genes and gene expression products |
| 04/06/2000 | WO2000018915A2 Membrane-associated organizational proteins |
| 04/06/2000 | WO2000018914A2 Novel dkr polypeptides |
| 04/06/2000 | WO2000018912A2 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases |
| 04/06/2000 | WO2000018910A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 04/06/2000 | WO2000018908A1 Use of specific hybrid promoters for controlling tissue expression |
| 04/06/2000 | WO2000018902A1 Method of screening for large offspring syndrome |
| 04/06/2000 | WO2000018896A1 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 04/06/2000 | WO2000018889A2 Sequenzes of putative plant acyltransferases |
| 04/06/2000 | WO2000018888A1 Immunomodulation by genetic modification of dendritic cells and b-cells |
| 04/06/2000 | WO2000018887A1 Method and apparatus for the storage of entomopathogenic nematodes |
| 04/06/2000 | WO2000018885A1 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 04/06/2000 | WO2000018884A1 Gene encoding mnr2 and uses thereof |
| 04/06/2000 | WO2000018804A1 Tie2 agonist antibodies |
| 04/06/2000 | WO2000018803A2 Antibodies to mammalian langerhans cell antigen and their uses |
| 04/06/2000 | WO2000018799A1 Artemin, a novel neurotrophic factor |
| 04/06/2000 | WO2000018796A2 Secretory protein- zsig48 |
| 04/06/2000 | WO2000018782A2 Hrpca 9 and hrpca 10 nucleic acids and polypeptides |
| 04/06/2000 | WO2000018438A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
| 04/06/2000 | WO2000018437A1 Tie2 antagonist antibodies |
| 04/06/2000 | WO2000018434A1 Mutant cholera holotoxin as an adjuvant |
| 04/06/2000 | WO2000018421A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 04/06/2000 | WO2000018414A1 Transplantation of neural cells for the treatment of ischemic damage due to stroke |
| 04/06/2000 | WO2000018413A1 Transplantation of neural cells for the treatment of chronic pain or spasticity |
| 04/06/2000 | WO2000018239A1 Reversibly immortalized hepatocytes and methods of use |
| 04/06/2000 | WO2000018212A2 Platelet-derived growth factor c, dna coding therefor, and uses thereof |